FDA — authorised 23 March 2022
- Application: NDA215833
- Marketing authorisation holder: NOVARTIS
- Status: supplemented
🇺🇸 Pluvicto in United States
FDA authorised Pluvicto on 23 March 2022
Marketing authorisations
FDA
- Status: approved
Other Oncology approved in United States
Frequently asked questions
Is Pluvicto approved in United States?
Yes. FDA authorised it on 23 March 2022; FDA has authorised it.
Who is the marketing authorisation holder for Pluvicto in United States?
NOVARTIS holds the US marketing authorisation.